Impact of an oral gonadotropin‐releasing hormone antagonist on severe ovarian hyperstimulation syndrome in a patient with breast cancer who received a sustained‐release gonadotropin‐releasing hormone agonist: A case report
2013 ◽
Vol 289
(1)
◽
pp. 223-225
◽
2020 ◽
Vol 17
(4)
◽
pp. 314-317
2005 ◽
Vol 84
(6)
◽
pp. 1745.e1-1745.e2
1992 ◽
Vol 9
(3)
◽
pp. 281-283
◽
2016 ◽
Vol 8
(5)
◽
pp. 396-401
◽
2010 ◽
Vol 93
(7)
◽
pp. 2418-2420
◽
2010 ◽
Vol 28
(06)
◽
pp. 468-474
◽
2015 ◽
Vol 32
(7)
◽
pp. 1063-1068
◽